A new daily pill has been approved by the U.S. Food and Drug Administration to treat advanced pancreatic cancer. This breakthrough medication works by choking off tumor growth, offering hope to families affected by the disease.

A 61-year-old patient, Karen Siciliano, who has been battling stage 4 pancreatic cancer for four years, has started taking the pill. She was given her first dose at a treatment facility. Siciliano's cancer diagnosis came after a routine CT scan.

Further details about her treatment and the new medication are available.